ALHC vs. IRTC: A Head-to-Head Stock Comparison
UpdatedHere’s a clear look at ALHC and IRTC, comparing key factors like performance, valuation metrics, dividends, and financial strength. It’s built for investors or anyone curious to see how these two stocks match up.
Company Overview
ALHC (3.03 billion USD) and IRTC (4.47 billion USD) sit neck-and-neck in market cap terms.
ALHC at 1.33 and IRTC at 1.34 move in sync when it comes to market volatility.
| Symbol | ALHC | IRTC |
|---|---|---|
| Company Name | Alignment Healthcare, Inc. | iRhythm Technologies, Inc. |
| Country | US | US |
| Sector | Healthcare | Healthcare |
| Industry | Medical - Healthcare Plans | Medical - Devices |
| CEO | Mr. John E. Kao | Mr. Quentin S. Blackford |
| Price | 15.33 USD | 139.87 USD |
| Market Cap | 3.03 billion USD | 4.47 billion USD |
| Beta | 1.327 | 1.344 |
| Exchange | NASDAQ | NASDAQ |
| IPO Date | March 26, 2021 | October 20, 2016 |
| ADR | No | No |
Performance Comparison
This chart compares the performance of ALHC and IRTC over the past year by tracking the growth of an initial $10,000 investment in each (starting one year ago).
Hover over the lines to see the investment’s value and total return (%) at specific dates.
Data is adjusted for dividends and splits.
Valuation Metrics Comparison
The section examines key financial ratios to assess the valuation of ALHC and IRTC based on earnings, cash flow, sales, and book value. Pay attention to the following notable points where extreme values stand out.
- Both ALHC at -32.75 and IRTC at -44.94 have negative P/E values over the past twelve months. This reflects consistent losses rather than profits, meaning their current operations aren’t generating positive net income—a situation that could challenge their financial stability if prolonged.
- Both ALHC at -1.11 and IRTC at -3.27 show negative Forward PEG values. This signals that analysts foresee either outright losses or a decline in earnings over the next period—a troubling outlook that casts doubt on their near-term profit potential.
| Symbol | ALHC | IRTC |
|---|---|---|
| Price-to-Earnings Ratio (P/E, TTM) | -32.75 | -44.94 |
| Forward PEG Ratio (TTM) | -1.11 | -3.27 |
| Price-to-Sales Ratio (P/S, TTM) | 1.01 | 7.22 |
| Price-to-Book Ratio (P/B, TTM) | 27.45 | 50.98 |
| Price-to-Free Cash Flow Ratio (P/FCF, TTM) | 159.00 | 320.26 |
| EV-to-EBITDA (TTM) | -64.47 | -68.66 |
| EV-to-Sales (TTM) | 0.86 | 7.80 |
| EV-to-Free Cash Flow (TTM) | 136.01 | 346.10 |
Dividend Comparison
Neither ALHC nor IRTC pays dividends, suggesting both reinvest all profits into growth—likely expansion or innovation—favoring long-term value over immediate income.
| Symbol | ALHC | IRTC |
|---|---|---|
| Dividend Yield (TTM) | 0.00% | 0.00% |
Financial Strength Metrics Comparison
This section dives into the financial resilience of ALHC and IRTC, spotlighting key metrics like liquidity, leverage, and debt coverage. Check out the standout observations below where notable differences or extremes pop up.
- IRTC’s 8.49 D/E breaches 3.0, loading up on debt that could test its resilience. In contrast, ALHC at 0.07 plays it closer to the vest with borrowing.
- ALHC at -2.98 and IRTC at -16.44 both scrape by with interest coverage under 1.5. Earnings are stretched thin against interest bills, leaving little wiggle room if profits drop.
| Symbol | ALHC | IRTC |
|---|---|---|
| Current Ratio (TTM) | 1.69 | 5.71 |
| Quick Ratio (TTM) | 1.69 | 5.58 |
| Debt-to-Equity Ratio (TTM) | 0.07 | 8.49 |
| Debt-to-Assets Ratio (TTM) | 0.01 | 0.79 |
| Interest Coverage Ratio (TTM) | -2.98 | -16.44 |